Cellebrite Di (CLBT)Officer sold ~$141K

~$141K

Approx. value · 13K sh @ $11.24

427K

Holds after · shares reported

Traded

Aug 21, 2026

Filed

Aug 25, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 2, 2026InsiderCEO sold ~$1.63M of CLBT shares in the open market
2. Jul 8, 2026InsiderCFO sold ~$683K of CLBT shares in the open market
3. Aug 12, 2026Insider · 3 peopleInsiders: 3 sales (~$2.2M)
4. Aug 21, 2026 · this disclosureInsiderOfficer sold ~$141K of CLBT shares in the open market

What came next

1. Aug 21, 2026InsiderOfficer sold ~$25K of CLBT shares in the open market
2. Aug 24, 2026InsiderOfficer sold ~$49K of CLBT shares in the open market
3. Aug 25, 2026InsiderInsider sold ~$286K of CLBT shares in the open market
4. Oct 9, 20265% stakePertento Partners LLP reported a passive stake (13G) of 5.2%

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cellebrite Di

For Cellebrite Di, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CLBT page.

Other recent filings by Marcus Jewell, Global Chief Revenue Officer

• SEC Form 4 at Cellebrite Di (CLBT)Aug 13, 2026
• SEC Form 4 at Cellebrite Di (CLBT)May 19, 2026
• SEC Form 4 at Cellebrite Di (CLBT)May 15, 2026

The full history of Marcus Jewell, Global Chief Revenue Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cellebrite Di

• SEC Schedule 13GOct 9, 2026
• SEC Form 4Aug 28, 2026
• SEC Form 4Aug 26, 2026
• SEC Form 4Aug 25, 2026
• SEC Form 4Aug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its CLBT page.